Over the course of five days, 6,000 scientists will share results from recent studies, spurring discussion and debate. Attendees can visit 400 exhibitors showcasing new tools and technologies. Presentations at the annual meeting will cover the latest basic, translational, clinical, and prevention-focused research in the field, including early detection, cancer interception, and survivorship in all populations.
The theme for the upcoming annual meeting is Driving Innovative Cancer Science to Patient Care, "a powerful reminder that at the heart of every scientific advance is a patient in urgent need of a cure."
AACR 2018 GuidesWith a meeting of this size and scope one could miss out on some very interesting science. The AACR has done a wonderful job providing information ahead of time, allowing you to optimize your attendance.
- There is a 245-page online Program Guide, providing the complete program schedule and additional information to help you decide what events to attend.
- The AACR Online Proceedings/Itinerary Planner can help you search, filter, and view abstracts.
- With their free app, you can develop your own itinerary, helping you navigate talks, exhibitor visits, and special sessions.
Mouse Models at AACR 2018
– Elaine R. Mardis, PhD,
Chair, 2018 Program
Committee and AACR
These mice are the basis for generating Human Immune System (HIS) mice, and there are over 300 AACR abstracts addressing HIS mice. These mice are used in xenograft studies to transfer human tumors into mice, allowing the tumors to grow for Patient Derived Xenograft (PDX) studies.
One poster utilizing HIS mice at this year's meeting is Cytokine-transgenic NOG mice engrafted with human peripheral blood cells support natural killer cell expansion (Poster Section 44). Dr. Paul Volden, Field Application Scientist at Taconic Biosciences, will present this poster.
Additionally, there are 778 abstracts using xenograft technology, 238 syngeneic studies, and over 700 abstracts referring to checkpoint inhibitors.
Other Activities at AACR 2018
Continuing EducationThe Satellite Educational Symposia, held in conjunction with the Annual Meeting, offers five CME-accredited courses:
- Cancer Immunotherapy Evidence, Biomarkers and Immune Combinations: Are We on the Verge of a New Generation? Bridging Research and Practice in the Quest for Better Tools to Harness the Potential of Immuno-Oncology
- Interactive Tumor Panel: Clinical Investigators Discuss Available Research Shaping the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Lung Cancer
- Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy
- Data & Perspectives: Biologic Basis for and Available Clinical Research Underlying the Protocol and Nonresearch Utilization of PARP Inhibition in Patients with Ovarian and Breast Cancer
- Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in Trials
Science and Advocacy PartnershipsA unique program sponsored by AACR is the Scientist↔Survivor Program, which builds partnerships among scientists and cancer survivor and patient advocacy communities. It supports the opportunity for these groups to interact during the annual meeting.
AACR Career FairThe AACR 2018 Career and Biomedical Research Career Fair is on Saturday, April 14. This is a great chance to meet with recruiters and employers in many sectors of the life science and biomedical industries.
Online Streaming AccessAll paid Annual Meeting registrants will receive exclusive online streaming access. Non-attendees will have the opportunity to purchase access to the webcast.
All presentations will be available by May 9.